Phathom Pharmaceuticals Inc (PHAT) Directors and Executive Officers - CSIMarket
CSIMarket
 
Phathom Pharmaceuticals Inc   (NASDAQ: PHAT)

Phathom Pharmaceuticals Inc

Officers & Directors


1. Dr. Azmi Nabulsi, President and CEO
Dr. Nabulsi holds a medical degree from the University of Jordan and a clinical pharmacology degree from the University of Glasgow.

2. Terri Phillips, Chief Financial Officer
Ms. Phillips holds a bachelor's degree in accounting from the University of Alabama, a master's degree in taxation from Golden Gate University and an MBA from Georgia State University.

3. Dr. Tadataka Yamada, Chairman of the Board
Dr. Yamada holds an MD degree from New York University Medical School and a PhD degree in microbiology from the University of Michigan.

4. David Socks, Senior VP Clinical Development, Medical Affairs and Regulatory Affairs
Mr. Socks holds a Bachelor of Science degree from Washington University in St. Louis and a master's degree in medical science from Harvard University.

5. Michelle Griffin, Senior VP, General Counsel, and Corporate Secretary
Ms. Griffin holds a JD degree from the University of Virginia and a BA from the University of North Carolina at Chapel Hill.

Board of Directors:

1. Dr. Tadataka Yamada (Chairman)
2. Jim Daly
3. Dov Goldstein
4. Miles White
5. John Orwin

Phathom Pharmaceuticals Inc currently has 371 employees.






PHAT Management Effectiveness PHAT Revenue per Employee PHAT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.